This is a preview of subscription content, log in via an institution to check access.
Rights and permissions
About this article
Cite this article
Rizatriptan preferred for migraine. Pharmacoecon. Outcomes News 339, 10 (2001). https://doi.org/10.1007/BF03280655
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03280655